Protective role of harmol against β-cell toxicity and glucose dysregulation in type 2 diabetes mellitus

Deepa Sugumar, Emdormi Rymbai, Ram Kothandan, Amritha Chakkittukandiyil, Praveen Thaggikuppe Krishnamurthy, Santhoshkumar Muthu, Divakar Selvaraj

Open source

DOI: 10.1016/j.ejphar.2025.177825
Published: 2025-09
Container: European Journal of Pharmacology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejphar.2025.177825,
  title = {Protective role of harmol against β-cell toxicity and glucose dysregulation in type 2 diabetes mellitus},
  author = {Deepa Sugumar and Emdormi Rymbai and Ram Kothandan and Amritha Chakkittukandiyil and Praveen Thaggikuppe Krishnamurthy and Santhoshkumar Muthu and Divakar Selvaraj},
  year = {2025},
  journal = {European Journal of Pharmacology},
  doi = {10.1016/j.ejphar.2025.177825},
  url = {https://doi.org/10.1016/j.ejphar.2025.177825}
}

RIS

TY  - JOUR
TI  - Protective role of harmol against β-cell toxicity and glucose dysregulation in type 2 diabetes mellitus
AU  - Deepa Sugumar
AU  - Emdormi Rymbai
AU  - Ram Kothandan
AU  - Amritha Chakkittukandiyil
AU  - Praveen Thaggikuppe Krishnamurthy
AU  - Santhoshkumar Muthu
AU  - Divakar Selvaraj
PY  - 2025
JO  - European Journal of Pharmacology
DO  - 10.1016/j.ejphar.2025.177825
UR  - https://doi.org/10.1016/j.ejphar.2025.177825
ER  -

APA

Sugumar, D., Rymbai, E., Kothandan, R., Chakkittukandiyil, A., Krishnamurthy, P. T., Muthu, S., & Selvaraj, D. (2025). Protective role of harmol against β-cell toxicity and glucose dysregulation in type 2 diabetes mellitus. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.177825

Source records

crossref · retrieved 2026-09-27T01:23:39.427Z